Navigation Links
Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
Date:4/28/2008

s of biomass grasses to biofuels production."

Cellulosic biofuels are made from leaves, stems, stalks or other typically non-edible parts of plants. Use of these renewable energy sources has the potential to greatly expand biofuel supply and also deliver environmental benefits such as reduced greenhouse gas emissions.

Mendel Biotechnology, Inc., has been a pioneer in the application of functional genomics to the study of plant genes. Mendel is also a pioneer for the production of dedicated energy crops critical for second generation biofuels. Mendel has identified and patented the use of genes that control many aspects of plant growth and development, and is using such inventions to develop or co-develop new plant varieties with improved productivity and quality. Mendel has relationships with leading agricultural, energy, forestry and horticulture companies for the commercialization of improved seed and plant products, and is developing new seed and feedstock products for the emerging bioenergy market. For more information, visit: http://www.mendelbio.com.

Monsanto Company is a leading provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information on Monsanto, see http://www.monsanto.com.


'/>"/>
SOURCE Monsanto Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Monsanto Executives to Address Investor Conferences in February
2. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
3. Monsantos R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
4. Monsanto and Devgen Describe New Approach to Insect-Protection
5. Monsanto Company Executives Adopt 10b5-1 Trading Plans
6. Science Magazine Recognizes Monsanto as Top Employer
7. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
8. Monsanto Company Sets Webcast and Analyst/Media Call for 2007 Fourth-Quarter and Fiscal-Year Financial Results
9. Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research
10. Monsanto Company Signs Share Subscription Agreement With Devgen
11. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 27, 2015 Dr. Robert Hanzlik, whose ... toxicity carries implications for advancing the creation of safer ... National University , the second-largest private, nonprofit university ... Hanzlik, a professor at the University of Kansas School ... design, starts at 5 p.m. and takes place at ...
(Date:4/27/2015)... April 27, 2015 ... please scroll to bottom . Investor-Edge ... Pharmaceuticals Inc. (NASDAQ: LXRX ), Idera Pharmaceuticals ... (NASDAQ: SNTA ), Spectrum Pharmaceuticals Inc. (NASDAQ: ... MDVN ). Free research report on Lexicon Pharma ...
(Date:4/27/2015)... and HEIDELBERG , Germany ... Addresses unmet need in treatment of millions of ... has been granted a patent in Europe ... patent supports Molecular Health,s discovery that EPHB4 is a novel ... promotes tumor growth. EPO stimulates the production of red blood ...
(Date:4/27/2015)... 2015 Diasome Pharmaceuticals, Inc. (“Diasome”) ... Joslin Diabetes Center (“Joslin”) to collaborate on the ... novel Hepatocyte Directed Vesicle (“HDV”) targeting system for ... , Located in Boston, Massachusetts, Joslin is the ... organization dedicated to the prevention, treatment and cure ...
Breaking Biology Technology:Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 2Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 3Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 2Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 3Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 4Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 5Molecular Health Gains Patent for Novel Receptor Utilizing Computational Biomarker Discovery Technology 2Diasome Pharmaceuticals Announces Clinical Trial Design Collaboration 2
... Imago Scientific Instruments has sold one of ... of Engineering for use in the new W.M. ... lab will be the primary research center of ISU's ... Narasimhan, an associate professor of chemical and biological engineering. ...
... has secured $5 million in a funding round led ... LLC. , ,The funding will allow Jellyfish to ramp up ... conjunction with the funding, retail industry veteran Ralph Dillon, managing ... of Directors. , ,Jellyfish has gained traction in online retailing ...
... research team at the Medical College of Wisconsin ... National Heart, Lung, and Blood Institute to support ... which was awarded to an investigative team led by pediatric ... molecular and clinical understanding of Von Willebrand disease ...
Cached Biology Technology:Online retailer Jellyfish.com lands $5M in funding 2Online retailer Jellyfish.com lands $5M in funding 3Medical College secures $9.7M research grant 2
(Date:4/9/2015)... Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the third quarter of ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-438-5524 (conference ...
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
(Date:3/31/2015)...   Guidepoint , a leading global research services ... Management TRACKER, part of the Guidepoint TRACKER ... medical device and therapeutics markets. The Post-Surgical Pain Management ... market share, and adoption rates across three major modalities ... The Post-Surgical Pain Management TRACKER will provide ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... the American Society of Tropical Medicine and Hygiene (ASTMH) -- ... bring together in one place global experts who are battling ... that each year kill or sicken hundreds of millions of ... medicine and global health will present new insights and research ...
... N.C. -- Recognizing that some of the leading ... are located in the Research Triangle Park area, ... $13.6 million grant to establish a multi-university center ... scientific endeavor. Researchers from Duke University, North ...
... Bethesda, MDA new commentary published online in The FASEB ... diligent and demand proof of safety and benefit before ... treatments have very little scientific evidence that they actually ... the article, Phillip J. Baker, Ph.D., Executive Director of ...
Cached Biology News:Latest on malaria, dengue, radiation threats, bedbugs, cholera in Haiti at ASTMH Annual Meeting 2Latest on malaria, dengue, radiation threats, bedbugs, cholera in Haiti at ASTMH Annual Meeting 3NSF establishes Triangle (NC) Center for Soft Matter Research 2NSF establishes Triangle (NC) Center for Soft Matter Research 3Chronic pain: Watch out before accepting diagnosis and treatment 2